Free Trial

MetLife, Inc. (NYSE:MET) Shares Sold by Commerce Bank

MetLife logo with Finance background

Commerce Bank decreased its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 4.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,944 shares of the financial services provider's stock after selling 6,203 shares during the quarter. Commerce Bank's holdings in MetLife were worth $10,305,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Segall Bryant & Hamill LLC acquired a new stake in MetLife in the third quarter valued at $1,074,000. Prospera Private Wealth LLC acquired a new stake in MetLife in the 3rd quarter valued at about $59,000. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in MetLife during the 3rd quarter valued at about $2,960,000. Banque Cantonale Vaudoise raised its position in MetLife by 426.4% during the third quarter. Banque Cantonale Vaudoise now owns 51,374 shares of the financial services provider's stock worth $4,237,000 after acquiring an additional 41,615 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC lifted its holdings in shares of MetLife by 7.5% in the third quarter. Fifth Third Wealth Advisors LLC now owns 9,693 shares of the financial services provider's stock valued at $799,000 after purchasing an additional 680 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company's stock.

MetLife Price Performance

MET stock opened at $82.60 on Thursday. The company has a market cap of $57.19 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 0.75 and a beta of 1.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a 50-day moving average price of $82.08 and a two-hundred day moving average price of $75.84. MetLife, Inc. has a 12-month low of $62.14 and a 12-month high of $86.94.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.64%. MetLife's dividend payout ratio (DPR) is 43.95%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on MET shares. Jefferies Financial Group upped their target price on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research note on Friday, September 27th. TD Cowen began coverage on shares of MetLife in a report on Wednesday, October 9th. They issued a "buy" rating and a $97.00 target price on the stock. Piper Sandler boosted their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Morgan Stanley decreased their target price on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research report on Monday, August 19th. Finally, Wells Fargo & Company increased their price target on MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. Fourteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, MetLife has an average rating of "Buy" and a consensus target price of $88.46.

Get Our Latest Research Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines